Stocks · News reference
VanEck has completed its TruSector ETF lineup with the launch of four new sector-focused ETFs, expanding the actively managed suite to cover all 11 Global Industry Classification Standard (GICS) sectors. The new
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AbbVie announced nine-year Phase 3 CLL14 trial data showing venetoclax plus obinutuzumab significantly improved progression-free survival (6.4 years vs 3.2 years) compared to chlorambucil plus obinutuzumab in previously untreated chronic lymphocytic leukemia patients. The fixed-duration combination demonstrated median time to next treatment of 7.6 years with sustained safety and efficacy.
Apple's post-earnings dip put tech ETFs in focus. Here's how diversified ETFs can help reduce Apple-specific risk and which funds have the highest AAPL exposure.